109 related articles for article (PubMed ID: 29447925)
1. DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma.
Tabata Y; Nakanishi Y; Hatanaka KC; Hatanaka Y; Tsuchikawa T; Okamura K; Noji T; Shichinohe T; Matsuno Y; Hirano S
Hum Pathol; 2018 Jun; 76():28-36. PubMed ID: 29447925
[TBL] [Abstract][Full Text] [Related]
2. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
Han Y; Zhang W; Liu Y
World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
[TBL] [Abstract][Full Text] [Related]
4. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Surrey LF; Frank R; Zhang PJ; Furth EE
Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
[TBL] [Abstract][Full Text] [Related]
5. Expression of Lamininγ2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(5):2099-102. PubMed ID: 25773857
[TBL] [Abstract][Full Text] [Related]
6. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
Li J; Yang Z; Huang S; Li D
Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
[TBL] [Abstract][Full Text] [Related]
7. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
Wang M; Gong B; Li Y; Wang Y
Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
[TBL] [Abstract][Full Text] [Related]
8. Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
Watanabe A; Suzuki H; Yokobori T; Tsukagoshi M; Altan B; Kubo N; Suzuki S; Araki K; Wada S; Kashiwabara K; Hosouchi Y; Kuwano H
Cancer Sci; 2014 Jun; 105(6):690-6. PubMed ID: 24708177
[TBL] [Abstract][Full Text] [Related]
9. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma.
Shimura T; Shibata M; Gonda K; Kofunato Y; Okada R; Ishigame T; Kimura T; Kenjo A; Marubashi S; Kono K; Takenoshita S
J Invest Surg; 2018 Dec; 31(6):475-482. PubMed ID: 28925763
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Maeda T; Taguchi K; Aishima S; Shimada M; Hintz D; Larusso N; Gores G; Tsuneyoshi M; Sugimachi K; Wands JR; de la Monte SM
Cancer Detect Prev; 2004; 28(5):313-8. PubMed ID: 15542253
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neutrophil distribution in cholangiocarcinoma.
Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of matriptase in tumor stroma is a poor prognostic indicator of extrahepatic bile duct cancer.
Komatsubara T; Oshiro H; Sakuma Y; Sata N; Niki T; Fukushima N
Pathol Int; 2019 Feb; 69(2):86-93. PubMed ID: 30729623
[TBL] [Abstract][Full Text] [Related]
14. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
[TBL] [Abstract][Full Text] [Related]
16. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
[TBL] [Abstract][Full Text] [Related]
17. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms.
Beyazit Y; Purnak T; Suvak B; Kurt M; Sayilir A; Turhan T; Tas A; Torun S; Celik T; Ibis M; Haznedaroglu IC
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):644-9. PubMed ID: 21802387
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ADAM19 and CUEDC2 expression in EHCC and their clinicopathological significance.
Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
Biomark Med; 2020 Nov; 14(16):1573-1584. PubMed ID: 32960074
[No Abstract] [Full Text] [Related]
19. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
[TBL] [Abstract][Full Text] [Related]
20. Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas.
Yamamoto H; Nakanishi Y; Mitsuhashi T; Hatanaka Y; Hatanaka K; Nange A; Yoshida Y; Ino N; Go M; Okamura K; Tsuchikawa T; Nakamura T; Noji T; Asano T; Matsui A; Tanaka K; Murakami S; Ebihara Y; Kurashima Y; Shichinohe T; Hirano S
Ann Surg Oncol; 2024 Mar; 31(3):2090-2100. PubMed ID: 38052736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
